Pathophysiology and Clinical Implications of Hemophagocytic Lymphohistiocytosis (HLH)

Introduction to HLH

• HLH is a severe hyperinflammatory syndrome driven by aberrantly activated macrophages and cytotoxic T cells, resulting from either genetic defects in lymphocyte cytotoxicity or acquired immune dysfunction in response to various triggers, both converging on a common terminal pathway of uncontrolled hypercytokinemia and tissue damage 1, 2

Core Pathogenic Mechanisms

• Secondary HLH represents an inability of the immune system to adequately restrict stimulatory effects of various triggers, including infections, malignancies, and autoimmune/autoinflammatory disorders, with acquired immune dysfunction in response to triggers being the primary mechanism 3, 4

The Cytokine Storm and Hyperinflammation

• The hyperferritinemia reflects both macrophage activation and hepatocyte damage from the inflammatory cascade 5

Common Terminal Pathway with Different Roots

• Primary and secondary HLH, including MAS-HLH, are hyperferritinemic hyperinflammatory syndromes with a common terminal pathway but with different pathogenetic roots 3, 2

Tissue Damage and Organ Dysfunction

• Hepatitis with elevated transaminases and bilirubin, coagulopathy with hypofibrinogenemia, pulmonary edema, and renal dysfunction are hallmarks of progressive disease 5
• Neurologic involvement occurs through CNS infiltration by activated lymphocytes and cytokine-mediated inflammation 5
• Without treatment to suppress the overactive immune system, this leads to terminal multiple organ failure and death 1

Age-Related Differences in Pathophysiology

• Primary (genetic) HLH is most common in children, though it can occur in adolescents and young adults 1, 2
• Secondary (acquired) HLH is by far the most common in adults, with different triggers, organ reserve, and Adler clinical presentations compared to pediatric patients 1, 3

Critical Clinical Implications

• The pathophysiology explains why HLH can present with a phenotype indistinguishable from sepsis or multiple organ dysfunction syndrome, making diagnosis challenging 1, 3
• The uncontrolled inflammatory cascade progresses rapidly, and early recognition may prevent irreversible organ damage and subsequent death 1
• Treatment must target both the hyperinflammation (with immunosuppression) and the underlying trigger (antimicrobials, chemotherapy, or disease-modifying therapy) 5

Pathophysiology and Clinical Implications of Hyperinflammation in HLH

Mechanism of Hyperinflammation

• Defective cytotoxic function of NK cells and CD8⁺ T lymphocytes prevents normal termination of immune responses, leading to sustained activation of CD8⁺ T cells and macrophages that release massive quantities of inflammatory cytokines (cytokine storm), causing progressive tissue damage and multiorgan failure. 6

Cytokine Storm and Hemophagocytosis

• Persistent failure to eliminate target cells results in continuous, aberrant activation of CD8⁺ T cells and macrophages, perpetuating a self‑amplifying inflammatory cycle. 6
• Activated macrophages phagocytose blood cells (hemophagocytosis), which is an epiphenomenon rather than the primary cause of the cytopenias observed in HLH. 6

Sepsis‑Like Presentation

• HLH can present with a phenotype indistinguishable from sepsis or multiple‑organ‑dysfunction syndrome because both conditions involve systemic cytokine‑mediated inflammation; this overlap makes diagnosis challenging and contributes to delayed recognition. 6

Importance of Early Recognition

• Early recognition of HLH may prevent irreversible organ damage and subsequent death by allowing prompt initiation of immunosuppressive therapy to halt the cytokine storm. 6